Connect with us

Politics

DEA Wants Feds To Grow Almost 1,000 Pounds Of Marijuana Next Year

Published

on

443,680 grams.

That’s how much marijuana the U.S. Drug Enforcement Administration (DEA) wants federally-licensed researchers to grow for use in scientific studies in 2018.

That amounts to a little more than 978 pounds of government-cultivated cannabis.

While that may sound like a lot, it’s actually a slight decrease from this year’s level.

The 2018 aggregate production quotas that DEA laid out in a Federal Register filing slated for publication on Wednesday are amounts the agency thinks will “provide for the estimated medical, scientific, research [and] industrial needs of the United States, lawful export requirements, and the establishment and maintenance of reserve stocks.”

In addition to establishing the quota of nearly 1,000 pounds of marijuana, DEA will allow the production of 384,460 grams of tetrahydrocannabinols (THC) in 2018.

The order, signed by Acting DEA Administrator Robert W. Patterson, also allocates quotas of 92,120 grams of cocaine, 40 grams of LSD, 45 grams of heroin, 30 grams of psilocybin, 30 grams of ibogaine and varying levels of many other substances.

The filing comes just a few days after DEA finalized 2017 drug production quotas, establishing a limit of 472,000 grams of marijuana and 409,000 grams of THC.

In comparison, the proposed reduction for 2018 seems to run counter to DEA’s stated goal of expanding marijuana research. If there are to be more studies, it would probably make sense to allow for an increased supply of cannabis.

But the reduction could also reflect the fact that the Trump administration’s U.S. Department of Justice, of which DEA is a part, doesn’t appear especially interested in additional studies on marijuana.

Since 1968, the only legal source of cannabis for researchers is a farm that the University of Mississippi operates under a license from the National Institute on Drug Abuse. Scientists have complained that it is difficult to obtain product from the facility and that it is often of low quality.

Last year, however, DEA moved to end the monopoly by creating a process to license additional cultivators.

But although the agency reportedly received at least 25 applications from would-be legal marijuana growers, higher-level Justice Department officials have blocked action on the proposals.

Members of Congress have pushed U.S. Attorney General Jeff Sessions to allow DEA to process the applications, but he hasn’t yet responded to a bipartisan letter about the issue.

However, Sessions said in a Senate Judiciary Committee hearing last month that allowing more research cultivation would be “healthy.”

For now, DEA seems to be operating under the assumption that researchers won’t need more than 1,000 pounds of marijuana for next year. However, that could change, as the agency often adjusts its quotas throughout the year as its assessment of needs changes.

This story was first published by Forbes.

If you value staying updated on cannabis news, please start a monthly Patreon pledge to support Marijuana Moment!

Tom Angell is the editor of Marijuana Moment. A 15-year veteran in the cannabis law reform movement, he covers the policy and politics of marijuana. Separately, he serves as chairman of the nonprofit Marijuana Majority. Previously he reported for Marijuana.com and MassRoots, and handled media relations and campaigns for Law Enforcement Against Prohibition and Students for Sensible Drug Policy. (Organization citations are for identification only and do not constitute an endorsement or partnership.)

Politics

Marijuana Isn’t Addictive, Former A.G. Eric Holder Says

Published

on

The nation’s former top law enforcement officer is not worried that the legalization of marijuana will lead to addiction.

“I’ve never seen any scientific evidence that points you to concerns about addiction through the use of marijuana,” former U.S. Attorney General Eric Holder said in an interview published on Friday by NY1.

The comments by the former A.G. call into question cannabis’s current status as a Schedule I drug. That category is supposed to be reserved only for substances with no medical value and a high potential for abuse. In fact, it would mean that marijuana should be moved to at least Schedule III, where drugs with “moderate to low potential for physical and psychological dependence” are categorized.

Although Holder did not move to reclassify cannabis when he had the power to do so as attorney general, he did specifically endorse such a change just months after leaving office.

“I certainly think it ought to be rescheduled,” he said in a 2015 interview with PBS.

And he still feels the same way.

“We need to move marijuana from Schedule I, so research can be done,” Holder said in the new NY1 interview. “It is classified now on the same level as heroin is, and clearly that is inappropriate.”

While he did nothing to officially recategorize marijuana as attorney general — and continually passed the buck to Congress when asked about the issue — Holder’s Justice Department did issue guidance, known as the Cole Memo, which generally allowed states to implement their own cannabis laws without federal interference.

Current Attorney General Jeff Sessions rescinded that memo earlier this year.

In the new interview, Holder said he thinks the federal government should continue letting states implement their own legalization laws.

“Let those be laboratories to see where we want to be,” he said. “I think if you allow the states to experiment we’ll ultimately come to a national consensus about what it is we ought to do with regard to marijuana.”

He also spoke about unfair enforcement of cannabis criminalization.

“One of the things that I am concerned about, though, is the racial disparity you see in the enforcement of marijuana laws,” he said. “You see African Americans, Latinos using marijuana at just about the same rates as whites, and yet seeing rates of arrest four, five times as great as it is for whites. That is something that I think is extremely troubling.”

Photo courtesy of US Embassy New Zealand.

If you value staying updated on cannabis news, please start a monthly Patreon pledge to support Marijuana Moment!
Continue Reading

Politics

Congressional Committee Protects Medical Marijuana From Jeff Sessions

Published

on

A powerful congressional panel voted on Thursday to continue shielding medical marijuana patients and providers who comply with state laws from prosecution by the federal government.

While the provision has been federal law since 2014, when it was first attached to legislation that funds the U.S. Department of Justice, its continuance has been in question because of recent efforts by Republican leadership to prevent votes on cannabis amendments. But in a stunning bipartisan move, the House Appropriations Committee voted to add the provision as a rider to legislation funding U.S. Attorney General Jeff Session’s department for Fiscal Year 2019.

Please visit Forbes to read the rest of this piece.

(Marijuana Moment’s editor provides some content to Forbes via a temporary exclusive publishing license arrangement.)

If you value staying updated on cannabis news, please start a monthly Patreon pledge to support Marijuana Moment!
Continue Reading

Politics

Congressional Republicans Block Votes On Hemp Amendments

Published

on

In the latest development in a series of anti-cannabis moves, congressional Republican leadership has blocked consideration of several industrial hemp amendments.

Supporters were seeking to attach the measures to the large-scale Farm Bill, which sets food and agriculture policy for the country, but the House Rules Committee on Wednesday decided that the proposals cannot be considered on the floor.

The anti-cannabis chairman of the panel did, however, reveal that a broader deal for industrial hemp might be in the works.

One of the measures the committee killed, submitted by Reps. James Comer (R-KY) and Earl Blumenauer (D-OR), along with a bipartisan list of cosponsors, would have legalized hemp and made it eligible for crop insurance.

“Hemp is a crop with a long and rich history in our country,” Comer said in introducing his amendment before the committee. “It was grown by many of our founding fathers.”

Comer, who is a former Kentucky agriculture commissioner, said his state’s existing industrial hemp research program, which is authorized under a previous Farm Bill enacted in 2014, “has been a great success.”

He also spoke about the economic potential of the plant. “Times are tough in rural america,” he said. “For rural Kentuckians, industrial hemp has provided a new crop and business opportunity.”

But in a party-line move, the committee voted 8 to 3 to reject a motion to add Comer’s amendment to the list of proposals approved for floor consideration.

Another hemp amendment, filed by Reps. Thomas Massie (R-KY) and Jared Polis (D-CO), would have removed hemp from the list of federally banned substances.

A third proposal, submitted by Rep. Andy Barr (R-KY), sought to create “a safe harbor for financial institutions that provide services to hemp legitimate businesses” that operate under state-authorized research programs.

“There is a proud history in American and in Kentucky [for hemp] as an agriculture product,” Barr said when testifying for his amendment, noting that it can be used in over 25,000 products.

Under current law, banks that work with legitimate hemp companies “fear reprisal from federal regulators,” Barr said, arguing that his proposed measure would protect financial institutions “from unnecessary interference from bank examiners and regulators” and give producers rights that “every other American crop enjoys.”

The committee did not hold specific votes on those two measures.

Rules Committee Chairman Pete Sessions (R-TX) has made a consistent practice of blocking cannabis measures from advancing over the past several years.

Sessions, seemingly mistakenly, told Comer during the Wednesday hearing that the U.S. Drug Enforcement Administration (DEA) has “a clause…that industrial hemp should be declassified under their Schedule I drugs, which they concur, which is the position you hold, too.”

A hemp lobbyist told Marijuana Moment in an email that he had not heard of the DEA taking a pro-hemp position.

Polis, who as a Rules Committee member made the unsuccessful motion to let the full House vote on Comer’s amendment, argued that hemp is a “common sense area” that enjoys bipartisan support. The measure, he said, would simply “treat industrial hemp as the agricultural commodity that it is.”

While Sessions and other GOP panel members were not swayed, the chairman did hint just before the vote that there may still be hope for hemp reform, saying that the issue would be “determined by an agreement that would be reached” with Senate Majority Leader Mitch McConnell (R-KY).

McConnell last month filed a hemp legalization bill, which Comer’s amendment closely modeled. Fully a fifth of the Senate is now signed on as cosponsoring that legislation, and the majority leader has already announced plans to attach his hemp language to the version of the Farm Bill being considered by the Senate this month.

While it is unclear what exactly Sessions was suggesting when he referred to an “agreement” with McConnell, it may have been a reference to the conference committee process that will merge the House and Senate’s respective versions of the Farm Bill into a single proposal after each chamber passes its legislation. If McConnell succeeds in attaching hemp legalization to the Senate bill, it would then be up for consideration as part of the final legislation sent to President Trump for signing into law.

In 2014, McConnell successfully inserted a provision to prevent federal interference in hemp research programs in that year’s version of the Farm Bill.

Congress Considers Three Hemp Amendments To Farm Bill

Photo courtesy of Chris Wallis // Side Pocket Images.

If you value staying updated on cannabis news, please start a monthly Patreon pledge to support Marijuana Moment!
Continue Reading
Advertisement

Stay Up To The Moment

Marijuana News
In Your Inbox

Support Marijuana Moment